Research Publications

Beyond hairy cell: the activity of cladribine in other hematologic malignancies.

In vivo targeting of B-cell lymphoma with glycan ligands of CD22.

Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine.

Cladribine in indolent non-Hodgkin's lymphoma.

Down's syndrome and Alzheimer's disease.